Ascendis Health Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

JSE:ASC Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
17 Dec 24	BuyR11,669,565	Dendrobium Capital (Pty) Ltd	Company	14,586,859	R0.80
10 Dec 24	BuyR87,360,773	Calibre Investment Holdings Proprietary Limited	Company	108,665,204	R0.80
09 Dec 24	BuyR12,337,226	A. Neethling	Individual	15,421,666	R0.80
03 Sep 24	SellR7,277,841	A. Neethling	Individual	9,097,350	R0.80

Insider Trading Volume

Insider Buying: ASC insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ASC?
Owner Type	Number of Shares	Ownership Percentage
Institutions	325,699	0.052%
VC/PE Firms	61,686,663	9.86%
General Public	63,200,408	10.1%
Individual Insiders	84,282,686	13.5%
Private Companies	416,255,914	66.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 11 shareholders own 89.9% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
37.6%	Calibre Investment Holdings Proprietary Limited	235,159,194	R211.6m	85.9%	no data
13.2%	A. Neethling	82,752,074	R74.5m	15.5%	no data
9.86%	International Finance Corporation	61,686,663	R55.5m	0%	0.2%
9%	Kefolile Health Investments Pty Ltd	56,321,482	R50.7m	0%	no data
7.7%	Cresthold (Pty) Ltd	48,187,648	R43.4m	0%	no data
6.17%	Kingston Kapitaal (Pty) Ltd	38,580,668	R34.7m	0%	no data
6.07%	Dendrobium Capital (Pty) Ltd	38,006,922	R34.2m	0%	no data
0.2%	Karsten Uwe Harald Wellner	1,280,489	R1.2m	0%	no data
0.052%	Excelsia Capital (Pty) Ltd	322,548	R290.3k	19.3%	0.03%
0.04%	Bharti Harie	250,123	R225.1k	0%	no data
0.0005%	State Street Global Advisors, Inc.	3,151	R2.8k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 05:12
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ascendis Health Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Marcelle Jankelow	Investec Bank Limited (SA)
Marcelle Jankelow	Investec Bank plc (UK)